×
(Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological ...
People also ask
INVESTORS · CAREERS · ABOUT · PIPELINE · SCIENCE ... Publications & Presentations · Partnerships. INVESTORS. Overview · Press ... Voyager Therapeutics (Nasdaq: VYGR) ...
Earnings announcement* for VYGR: May 14, 2024. Voyager Therapeutics, Inc. Common Stock is estimated to report earnings on 05/14/2024. The upcoming earnings date ...
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Get the latest Voyager Therapeutics, Inc. (VYGR) stock news and headlines to help you in your trading and investing decisions.
Missing: relations | Show results with:relations
Voyager Therapeutics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View VYGR financial statements in full.
Investor Relations: Sarah McCabe. Stern Investor Relations, Inc. 212-362-1200. sarah@sternir.com. Media: Katie Engleman Pure Communications, Inc. 910-509-3977.